Phase I/II study of azacitidine, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy (Q38245311)
Jump to navigation
Jump to search
scientific article published on August 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I/II study of azacitidine, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy |
scientific article published on August 2014 |
Statements
1 reference
Phase I/II study of azacitidine, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy (English)
1 reference
Rakesh Singal
1 reference
Kavitha Ramachandran
1 reference
Edna Gordian
1 reference
Carlos Quintero
1 reference
Wei Zhao
1 reference
Isildinha M Reis
1 reference
1 August 2014
1 reference
1 reference
13
1 reference
1
1 reference
22-31
1 reference
Identifiers
1 reference
1 reference